Avicenna.ai

Avicenna.ai is a medical imaging artificial intelligence (AI) company that develops AI solutions to identify, detect, and quantify severe pathologies from computed tomography (CT) medical images. The company utilizes deep learning and machine learning technologies to optimize radiologists' manual tasks through high-performance tools. Its flagship product line, called CINA, leverages deep learning algorithms to identify acute abnormalities and support emergency room triage.

Avicenna.ai's AI tools seamlessly integrate into radiologists' clinical workflows, automatically triggering and reporting algorithm results through existing systems. These tools can detect various life-threatening conditions, such as intracranial hemorrhage, large vessel occlusion, aortic dissection, pulmonary embolism, and vertebral compression fractures. For instance, CINA-ICH detects suspected intracranial hemorrhage on non-contrast CT scans, reducing turnaround time for head trauma and stroke patients. CINA-LVO swiftly detects large vessel occlusion in the anterior circulation and prioritizes these cases for radiologists.

The company has secured multiple FDA clearances and CE marks for its AI solutions, validating their accuracy, sensitivity, and specificity across diverse CT scanner models. In June 2024, the company received FDA clearance for its CINA-VCF tool, which detects unsuspected vertebral compression fractures in chest or abdomen CT scans. The company has also obtained patents for its disruptive approach to using deep learning in therapeutic decision-making.

Key customers and partnerships

In July 2024, Avicenna.ai secured Medical Device Regulation (MDR) certification from BSI Medical Devices for its suite of AI tools for neurovascular and vascular conditions, ensuring compliance with the European Union's stringent medical device regulations.

The company has established commercial partnerships with leading market players in the US, Europe, and Asia. In April 2022, Avicenna.ai signed a distribution agreement with Sectra, an international medical imaging IT company, to offer its AI solutions for neurovascular pathologies through Sectra's Amplifier Marketplace. This partnership aims to provide radiologists with enhanced diagnostic confidence for stroke cases.

Additionally, in November 2020, Avicenna.ai partnered with Canon Medical Systems Corporation to deliver its FDA-approved CINA Head triage AI solution for neurovascular emergencies, integrated into Canon's Automation Platform. This collaboration demonstrates Avicenna.ai's commitment to providing innovative AI solutions to healthcare providers.